Q2 2024 – Leukemia & Lymphoma Society

For Q2 of 2024, AG2 has chosen the Leukemia & Lymphoma Society to receive a $2500 donation

The Leukemia & Lymphoma Society is the largest nonprofit funder of leading-edge research for every type of blood cancer, including leukemia, lymphoma, myeloma, and other rare types of blood cancers. They make thoughtful investments in blood cancer research that will lead to scientific breakthroughs that will improve and save the lives of patients. The LLS Research Team oversees the organization’s research agenda and manages our portfolio to support cutting-edge research for every type of blood cancer.

 

related posts

Q3 2024 – St. Jude Children’s Research Hospital

For Q3 of 2024, AG2 has chosen St. Jude Children's Research Hospital to receive a $2500 donation St. ...

read more

Q1 2024 – American Cancer Society

For Q1 of 2024, AG2 has chosen American Cancer Society to receive a $2500 donation The American Cancer ...

read more

Q4 2023 – Opportunity Village

For Q4 of 2023, Aruze has chosen Opportunity Village to receive a $2500 donation. Opportunity Village has...

read more